BELKIN Laser is pleased to announce the appointment of Andrew Webb as Chief Commercial Officer. Responsible for bringing our accessible, automated, fast, and non-invasive glaucoma laser treatment to market, Andrew will expertly guide the company to successful commercialisation anticipated in 2022 with a controlled roll-out in Europe.
Andrew brings significant industry experience having worked with industry giants like Bausch & Lomb, Johnson and Johnson and Rayner. He has over 30 years of experience in sales, marketing, M&A and general management, notably as VP Commercial, Surgical EMEA for Bausch & Lomb where he was a member of the global surgical management team. He holds an MBA from Henley Business School in England.
FURTHER INFORMATION:
BELKIN Laser
